EPIX Therapeutics Overview
- Year Founded
-
2007
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
EPIX Therapeutics General Information
Description
Developer of a next-generation ablation catheter technology designed to treat Atrial Fibrillation. The company helps to improve the treatment of AFIB through the introduction of products based on its proprietary catheter and generator system, enabling patients with a medical device to treat irregular heart rhythms.
Contact Information
Website
www.actmed.netCorporate Office
- 2880 Lakeside Drive
- Suite 250
- Santa Clara, CA
- United States
Corporate Office
- 2880 Lakeside Drive
- Suite 250
- Santa Clara, CA
- United States
EPIX Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Merger/Acquisition | 01-Jul-2023 | Completed | Generating Revenue | |||
| 8. Merger/Acquisition | 01-Mar-2019 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series C) | 27-Sep-2018 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series B) | 02-May-2017 | Completed | Product Development | |||
| 5. Later Stage VC (Series A2) | 10-Apr-2014 | Completed | Product Development | |||
| 4. Early Stage VC | 29-Aug-2011 | Completed | Product Development | |||
| 3. Early Stage VC (Series B) | 11-Nov-2010 | Completed | Product Development | |||
| 2. Early Stage VC | 21-Oct-2010 | $1.2M | $1.55M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 18-Mar-2009 | $350K | $350K | Completed | Startup |
EPIX Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B | ||||||||
| Series A2 | ||||||||
| Series A1 | 1,657,982 | $0.001000 | $0.08 | $1.05 | $1.05 | 1x | $1.05 | 3.77% |
| Series 1 | 338,545 | $0.001000 | $0.11 | $1.43 | $1.43 | 1x | $1.43 | 0.77% |
EPIX Therapeutics Patents
EPIX Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3860484-A1 | Lesion formation assessment and display | Pending | 05-Oct-2018 | ||
| US-11642166-B2 | Lesion formation assessment and display | Active | 05-Oct-2018 | ||
| US-12349965-B2 | Lesion formation assessment and display | Active | 05-Oct-2018 | ||
| US-20200107877-A1 | Lesion formation assessment and display | Active | 05-Oct-2018 | ||
| US-20230248427-A1 | Lesion formation assessment and display | Active | 05-Oct-2018 | A61B18/1492 |
EPIX Therapeutics Former Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ajax Health | PE/Buyout | Minority | ||
| Hansen Medical | Corporation | Minority | ||
| Keiretsu Forum | Angel Group | Minority | ||
| Life Science Angels | Angel Group | Minority | ||
| Medtronic | Corporation | Majority |
EPIX Therapeutics FAQs
-
When was EPIX Therapeutics founded?
EPIX Therapeutics was founded in 2007.
-
Where is EPIX Therapeutics headquartered?
EPIX Therapeutics is headquartered in Santa Clara, CA.
-
What industry is EPIX Therapeutics in?
EPIX Therapeutics’s primary industry is Surgical Devices.
-
Is EPIX Therapeutics a private or public company?
EPIX Therapeutics is a Private company.
-
What is EPIX Therapeutics’s current revenue?
The current revenue for EPIX Therapeutics is .
-
How much funding has EPIX Therapeutics raised over time?
EPIX Therapeutics has raised $77.8M.
-
Who are EPIX Therapeutics’s investors?
Ajax Health, Hansen Medical, Keiretsu Forum, Life Science Angels, and Medtronic are 5 of 10 investors who have invested in EPIX Therapeutics.
-
When was EPIX Therapeutics acquired?
EPIX Therapeutics was acquired on 01-Jul-2023.
-
Who acquired EPIX Therapeutics?
EPIX Therapeutics was acquired by Siemens Healthineers.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process